South Dakota § 58-29G-3 Requiring claim or utilization data restricted--Exclusion.

South Dakota Statutes

§ 58-29G-3 — Requiring claim or utilization data restricted--Exclusion.

South Dakota § 58-29G-3

Title 58INSURANCE

Ch. 58-29FPHARMACY AUDIT INTEGRITY PROGRAM

This text of South Dakota § 58-29G-3 (Requiring claim or utilization data restricted--Exclusion.) is published on Counsel Stack Legal Research, covering South Dakota primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook

S.D. Codified Laws § 58-29G-3 (2026).

Text

A pharmaceutical manufacturer may not, directly or indirectly, require a 340B entity or pharmacy to submit any claim or utilization data, as a condition for allowing the acquisition of a 340B drug by, or delivery of a 340B drug to, a 340B entity, unless the claim or utilization data sharing is required by federal law. Nothing in this section prohibits a pharmaceutical manufacturer from conducting an audit of a 340B entity, in accordance with 42 U.S.C. § 256b(a)(5)(C) (January 1, 2025).

Free access — add to your briefcase to read the full text and ask questions with AI

A pharmaceutical manufacturer may not, directly or indirectly, require a 340B entity or pharmacy to submit any claim or utilization data, as a condition for allowing the acquisition of a 340B drug by, or delivery of a 340B drug to, a 340B entity, unless the claim or utilization data sharing is required by federal law. Nothing in this section prohibits a pharmaceutical manufacturer from conducting an audit of a 340B entity, in accordance with 42 U.S.C. § 256b(a)(5)(C) (January 1, 2025).